169 related articles for article (PubMed ID: 36269317)
1. Intravesical injection of botulinum toxin type a may be an effective treatment option for autonomic dysreflexia in patients with high-level spinal cord injury.
Huang M; Zheng H; Huang T; Yang X; Liu Q; Li Q; Tang P; Xie K; Chen H
J Spinal Cord Med; 2024 Jan; 47(1):74-78. PubMed ID: 36269317
[TBL] [Abstract][Full Text] [Related]
2. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.
Schurch B; Stöhrer M; Kramer G; Schmid DM; Gaul G; Hauri D
J Urol; 2000 Sep; 164(3 Pt 1):692-7. PubMed ID: 10953127
[TBL] [Abstract][Full Text] [Related]
3. Effect of intravesical botulinum toxin injection on symptoms of autonomic dysreflexia in a patient with chronic spinal cord injury: a case report.
Jung IY; Mo KI; Leigh JH
J Spinal Cord Med; 2019 Nov; 42(6):806-809. PubMed ID: 28486884
[No Abstract] [Full Text] [Related]
4. Reduction in Bladder-Related Autonomic Dysreflexia after OnabotulinumtoxinA Treatment in Spinal Cord Injury.
Fougere RJ; Currie KD; Nigro MK; Stothers L; Rapoport D; Krassioukov AV
J Neurotrauma; 2016 Sep; 33(18):1651-7. PubMed ID: 26980078
[TBL] [Abstract][Full Text] [Related]
5. Protocol for a phase II, open-label exploratory study investigating the efficacy of fesoterodine for treatment of adult patients with spinal cord injury suffering from neurogenic detrusor overactivity for amelioration of autonomic dysreflexia.
Walter M; Ramirez AL; Lee AH; Rapoport D; Kavanagh A; Krassioukov AV
BMJ Open; 2018 Nov; 8(11):e024084. PubMed ID: 30467135
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.
Mehta S; Hill D; McIntyre A; Foley N; Hsieh J; Ethans K; Teasell RW; Loh E; Welk B; Wolfe D
Arch Phys Med Rehabil; 2013 Aug; 94(8):1473-81. PubMed ID: 23632286
[TBL] [Abstract][Full Text] [Related]
7. Intradetrusor OnabotulinumtoxinA Injections Ameliorate Autonomic Dysreflexia while Improving Lower Urinary Tract Function and Urinary Incontinence-Related Quality of Life in Individuals with Cervical and Upper Thoracic Spinal Cord Injury.
Walter M; Kran SL; Ramirez AL; Rapoport D; Nigro MK; Stothers L; Kavanagh A; Krassioukov AV
J Neurotrauma; 2020 Sep; 37(18):2023-2027. PubMed ID: 32631152
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
Utomo E; Groen J; Blok BF
Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
[TBL] [Abstract][Full Text] [Related]
9. Autonomic dysreflexia during urodynamics in children and adolescents with spinal cord injury or severe neurologic disease.
Canon S; Shera A; Phan NM; Lapicz L; Scheidweiler T; Batchelor L; Swearingen C
J Pediatr Urol; 2015 Feb; 11(1):32.e1-4. PubMed ID: 25697979
[TBL] [Abstract][Full Text] [Related]
10. Botulinum Toxin A Injection for Autonomic Dysreflexia-Detrusor Injection or Urethral Sphincter Injection?
Chow PM; Kuo HC
Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828422
[TBL] [Abstract][Full Text] [Related]
11. A pilot prospective study to evaluate whether the bladder morphology in cystography and/or urodynamic may help predict the response to botulinum toxin a injection in neurogenic bladder refractory to anticholinergics.
Álvares RA; Araújo ID; Sanches MD
BMC Urol; 2014 Aug; 14():66. PubMed ID: 25123234
[TBL] [Abstract][Full Text] [Related]
12. Effects of intravesical onabotulinumtoxinA on bladder dysfunction and autonomic dysreflexia after spinal cord injury: role of nerve growth factor.
Elkelini MS; Bagli DJ; Fehlings M; Hassouna M
BJU Int; 2012 Feb; 109(3):402-7. PubMed ID: 21733076
[TBL] [Abstract][Full Text] [Related]
13. Combined detrusor-trigone BTX-A injections for urinary incontinence secondary to neurogenic detrusor overactivity.
Hui C; Keji X; Chonghe J; Ping T; Rubiao O; Jianweng Z; Xiangrong D; Liling Z; Maping H; Qingqing L; Qiuling L; Jiebing H; Tanghai H
Spinal Cord; 2016 Jan; 54(1):46-50. PubMed ID: 26261074
[TBL] [Abstract][Full Text] [Related]
14. A single-blind randomized control trial of trigonal versus nontrigonal Botulinum toxin-A injections for patients with urinary incontinence and poor bladder compliance secondary to spinal cord injury.
Chen H; Xie K; Jiang C
J Spinal Cord Med; 2021 Sep; 44(5):757-764. PubMed ID: 32003644
[No Abstract] [Full Text] [Related]
15. Injections of Botulinum Toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury.
Chen G; Liao L
Int Urol Nephrol; 2011 Sep; 43(3):655-62. PubMed ID: 21110094
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of fesoterodine for prevention of autonomic dysreflexia in patients with neurogenic dysfunction of the bladder after spinal cord injury].
Salyukov RV; Kamalov AA; Okhobotov DA; Chalyi ME; Frolova MV
Urologiia; 2023 Jul; (3):47-51. PubMed ID: 37417411
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of trigonal BTX-A injections for children with neurological detrusor overactivity secondary to spinal cord injury.
Hui C
J Pediatr Surg; 2020 Dec; 55(12):2736-2739. PubMed ID: 32571538
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
Schurch B; de Sèze M; Denys P; Chartier-Kastler E; Haab F; Everaert K; Plante P; Perrouin-Verbe B; Kumar C; Fraczek S; Brin MF;
J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A for refractory neurogenic detrusor overactivity in spinal cord injured patients in Singapore.
Tow AM; Toh KL; Chan SP; Consigliere D
Ann Acad Med Singap; 2007 Jan; 36(1):11-7. PubMed ID: 17285181
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin-type A in the treatment of drug-resistant neurogenic detrusor overactivity secondary to traumatic spinal cord injury.
Patki PS; Hamid R; Arumugam K; Shah PJ; Craggs M
BJU Int; 2006 Jul; 98(1):77-82. PubMed ID: 16831148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
